About Us
Endovascular Engineering, Inc. (“E2”), is a mission-driven, venture-backed company focused on the development and deployment of next generation clot removal technologies that target venous thromboembolism.
COMPANY VISION
OUR TEAM
Endovascular Engineering (“E2”) is led by an experienced team of engineers, clinicians, and medical device leaders with decades of experience and a proven track record in developing and commercializing endovascular technologies. In collaboration with leading clinical partners, we are dedicated to advancing the treatment of venous thromboembolism and improving outcomes for patients.
Leadership Team
Key Clinical Partners
















